Efficacy of a commercial vaccine containing Histophilus somni and Mannheimia haemolytica leukotoxoid (HIPRABOVIS® SOMNI/Lkt) under field conditions
Efficacy of a commercial vaccine containing Histophilus somni and Mannheimia haemolytica leukotoxoid (HIPRABOVIS® SOMNI/Lkt) under field conditions
The aim of this study was to confirm the efficacy of a commercial vaccine containing Histophilus somni and Mannheimia haemolytica leukotoxoid (HIPRABOVIS® SOMNI/Lkt) in reducing clinical respiratory signs and the number of concomitant treatments under field conditions.
The contents of this page are country specific and aimed specifically at prescribing veterinarians.
This product is not available in {{ preferredCountry.title }}.
You will be redirected to our global site. Click on continue to visit our global site (available in English).
Confirm that you are a veterinary professional:
- I am a veterinarian (otherwise please contact a veterinary professional)
Select your country:
Country
{{countrySelect.title}}
- Global (available in English)
- {{country.title}}
